A Mixed Intervention to Improve Resilience for Patient With Neurocognitive Disorders

Last updated: May 2, 2025
Sponsor: Centre Hospitalier Universitaire de Nice
Overall Status: Active - Recruiting

Phase

N/A

Condition

Memory Loss

Dementia

Mental Disability

Treatment

cognitive stimulation

mixed intervention

Clinical Study ID

NCT06801171
24-AOI-02
  • Ages > 60
  • All Genders

Study Summary

The study aims to test a program combining cognitive behavioral therapy techniques, positive psychology techniques, mindfulness meditation and yoga, in order to improve resilience in patient with minor cognitive disorder.

This intervention will be compared to a control group, but also with a group testing another intervention (an intervention that does not improve resilience in the elderly, namely a "cognitive stimulation" intervention) in order to ensure that the effect potentially obtained is not due to the simple management of the participant.

The duration of the intervention will be 3 months, with an evaluation directly before and after the intervention.

In addition, in order to best evaluate the effectiveness of the interventions over time, two follow-up measurements will be proposed: a measurement one month after the intervention, then a final one three months after the intervention.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  1. Man or Woman aged > 60 years

  2. Have a minor neurocognitive disorder according to the criteria of the DSM 5

  3. Score of 145 or less on the Wagnild and Young Resilience Scale (RS) (Wagnild, 2009).

  4. Subject able to read and write French;

  5. Subject beneficiaries of a social security scheme;

  6. Ability to understand and sign free and informed consent.

Exclusion

Exclusion Criteria:

  1. Subject already practicing meditation and/or yoga and/or Tai Chi

  2. Subject currently undergoing psychological therapy (whatever the approach)

  3. Subject with a major hearing, visual or motor disability likely to interfere withthe proposed interventions or the performance of assessments;

  4. Presence and/or recent history (within the last 5 years prior to inclusion in thestudy) of major psychiatric disorders (e.g., schizophrenia, severe depression,addiction, bipolar disorders, psychotic disorders, risk of dissociation, panicattack, generalized anxiety disorder, etc.)

  5. If taking psychotropic treatment, the dose must have been stable for 4 weeks

  6. Vulnerable persons are defined in Articles L1121-5 to -8

Study Design

Total Participants: 90
Treatment Group(s): 2
Primary Treatment: cognitive stimulation
Phase:
Study Start date:
April 30, 2025
Estimated Completion Date:
December 01, 2027

Connect with a study center

  • CHU de Nice

    Nice, 06003
    France

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.